[go: up one dir, main page]

GB9810299D0 - Use of nitric oxide synthase inhibitors - Google Patents

Use of nitric oxide synthase inhibitors

Info

Publication number
GB9810299D0
GB9810299D0 GBGB9810299.9A GB9810299A GB9810299D0 GB 9810299 D0 GB9810299 D0 GB 9810299D0 GB 9810299 A GB9810299 A GB 9810299A GB 9810299 D0 GB9810299 D0 GB 9810299D0
Authority
GB
United Kingdom
Prior art keywords
nitric oxide
oxide synthase
synthase inhibitors
inhibitors
nitric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9810299.9A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB9810299.9A priority Critical patent/GB9810299D0/en
Publication of GB9810299D0 publication Critical patent/GB9810299D0/en
Priority to MA25569A priority patent/MA24854A1/fr
Priority to PE1999000395A priority patent/PE20000474A1/es
Priority to ARP990102245A priority patent/AR020587A1/es
Priority to PCT/EP1999/003265 priority patent/WO1999059566A1/en
Priority to AU40406/99A priority patent/AU4040699A/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB9810299.9A 1998-05-15 1998-05-15 Use of nitric oxide synthase inhibitors Ceased GB9810299D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB9810299.9A GB9810299D0 (en) 1998-05-15 1998-05-15 Use of nitric oxide synthase inhibitors
MA25569A MA24854A1 (fr) 1998-05-15 1999-05-05 Inhibiteurs d'oxyde nitrique synthase
PE1999000395A PE20000474A1 (es) 1998-05-15 1999-05-12 Inhibidores de la oxido nitrico sintasa
ARP990102245A AR020587A1 (es) 1998-05-15 1999-05-12 Metodo para la profilaxis o tratamiento de una infeccion bacteriana en mamiferos, uso de un inhibidor de oxido nitrico sintasa inducible para lafabricacion de medicamentos y formulacion farmaceutica
PCT/EP1999/003265 WO1999059566A1 (en) 1998-05-15 1999-05-12 Use of nitric oxide synthase inhibitors in the manufacture of a medicament for the prophylaxis or treatment of bacterial infection
AU40406/99A AU4040699A (en) 1998-05-15 1999-05-12 Use of nitric oxide synthase inhibitors in the manufacture of a medicament for the prophylaxis or treatment of bacterial infection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9810299.9A GB9810299D0 (en) 1998-05-15 1998-05-15 Use of nitric oxide synthase inhibitors

Publications (1)

Publication Number Publication Date
GB9810299D0 true GB9810299D0 (en) 1998-07-15

Family

ID=10832007

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9810299.9A Ceased GB9810299D0 (en) 1998-05-15 1998-05-15 Use of nitric oxide synthase inhibitors

Country Status (6)

Country Link
AR (1) AR020587A1 (es)
AU (1) AU4040699A (es)
GB (1) GB9810299D0 (es)
MA (1) MA24854A1 (es)
PE (1) PE20000474A1 (es)
WO (1) WO1999059566A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0031179D0 (en) * 2000-12-21 2001-01-31 Glaxo Group Ltd Nitric oxide synthase inhibitors
US20040087653A1 (en) * 2002-05-16 2004-05-06 Manning Pamela T. Methods for the treatment of respiratory diseases and conditions with a selective iNOS inhibitor and a PDE inhibitor and compositions therefor
US8524735B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US7838532B2 (en) 2005-05-18 2010-11-23 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
NO2344129T3 (es) 2008-10-07 2018-07-21
PT2346509T (pt) 2008-10-07 2020-08-05 Horizon Orphan Llc Inalação de levofloxacina para redução da inflamação pulmonar
BR112012004692B8 (pt) 2009-09-04 2021-05-25 Mpex Pharmaceuticals Inc solução que compreende levofloxacina para uso em um método para tratar a fibrose cística em um ser humano
DE102010055322A1 (de) * 2010-12-21 2012-06-21 Christian-Albrechts-Universität Zu Kiel Antibakteriell und antimykotisch wirkende Substanzen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5312835A (en) * 1989-09-13 1994-05-17 Board Of Regents, The University Of Texas System Use of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotension
US5545625A (en) * 1994-12-12 1996-08-13 The Medical College Of Wisconsin Research Foundation, Inc. Preventing conversion of citrulline to argininosuccinate to limit pathological nitric oxide overproduction
GB9425701D0 (en) * 1994-12-20 1995-02-22 Wellcome Found Enzyme inhibitors
MY117948A (en) * 1997-01-13 2004-08-30 Glaxo Group Ltd Nitride oxide synthase inhibitors.
GB9702312D0 (en) * 1997-02-05 1997-03-26 Univ London Method for identifying selective inhibitors of nitric oxide synthase

Also Published As

Publication number Publication date
AR020587A1 (es) 2002-05-22
AU4040699A (en) 1999-12-06
PE20000474A1 (es) 2000-06-06
MA24854A1 (fr) 1999-12-31
WO1999059566A1 (en) 1999-11-25

Similar Documents

Publication Publication Date Title
AP2000001998A0 (en) Nitric oxide synthase inhibitors
AU4430599A (en) Inhibitors of nitric oxide synthase
CY2263B1 (en) Nitric oxide synthase inhibitors
GB0031179D0 (en) Nitric oxide synthase inhibitors
AU4149696A (en) Substituted heterocycles as inhibitors of nitric oxide synthase
AU2002222252A1 (en) Nitric oxide synthase inhibitor phosphate salt
IS5053A (is) 6-Fenýlpýridýl-2-amín afleiður nytsamlegar sem nituroxíð sýntasa tálmar
AU4515896A (en) Substituted 2-acylamino-pyridines as inhibitors of nitric oxide synthase
IL154841A (en) 2-amino-2-alkyl-5- heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors and intermediates
IL137654A0 (en) Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors
IL131047A0 (en) Use of il-18 inhibitors
GB9810299D0 (en) Use of nitric oxide synthase inhibitors
IL132678A0 (en) Amidine derivatives as inhibitors of nitric oxide synthase
AU8473398A (en) 1,3-diaza- heterocycles and their use as nitric oxide synthase inhibitors
AU1539399A (en) Inhibitors of nitric oxide synthase
AU2002355706A8 (en) Arylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase
EP1127156A4 (en) REGULATION OF THE ACTIVITY OF NITROGEN MONOXIDE SYNTHASE
HRP980381B1 (en) Nitric oxide synthase inhibitors
SI1084104T1 (en) Nitric oxide synthase inhibitors
SI0958277T1 (en) Nitric oxide synthase inhibitors
AU4821799A (en) Heterobicyclic and tricyclic nitric oxide synthase inhibitors
GB0031177D0 (en) Nitric oxide synthase inhibitors
GB9315159D0 (en) Nitric oxide synthase inhibitors
GB9303221D0 (en) Nitric oxide synthase inhibitors
IL130638A0 (en) Pharmaceutical compositions comprising nitric oxide synthase inhibitors

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)